TFXTeleflex Incorporated

$5B

Q2 2018 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$610M+15.4% YoY

Gross Profit

$345M56.5% margin

Operating Income

$33M5.5% margin

Net Income

-$2M-0.4% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

+3.9%

Cash Flow

Operating Cash Flow

$94M

Free Cash Flow

$72M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$6.2B

Total Liabilities

$3.7B

Stockholders' Equity

$2.4B

Cash & Equivalents

$346M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$610M	$529M	+15.4%
Gross Profit	$345M	$290M	+18.8%
Operating Income	$33M	$110M	-69.6%
Net Income	-$2M	$78M	-103.2%

Revenue Segments

Vascular Access

$141M25%

Other

$112M20%

Surgical

$90M16%

Anesthesia

$90M16%

Interventional

$77M14%

Interventional Urology

$48M9%

Geographic Segments

UNITED STATES

$356M61%

EMEA

$169M29%

Asia

$60M10%

TFX Q2 2018 Earnings — Teleflex Incorporated Revenue & Financial Results | Market Cap Arena